A Study of the Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine Headaches
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and effectiveness of topiramate as compared
to placebo for the prevention of headaches in patients with chronic migraine. Topiramate has
been approved to prevent migraine headaches as well as in the treatment of epilepsy.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.